Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]CStone Pharmaceuticals"
Count: 26
Selected: 0
NCT IDTitle
NCT03802591A Study of CS1001 in Subjects With Gastric Adenocarcinoma or Gastro-Esophageal Junction Adenocarcinoma
NCT05381753Safety and Efficacy of Avapritinib in Chinese Patients With Gastrointestinal Stromal Tumor (GIST) in the Real World
NCT04254939A Study of CS3007 in Subjects With Gastrointestinal Stromal Tumor
NCT03523819A Study of CS1002 in Subjects With Advanced Solid Tumors
NCT04176393A China Bridging Study of Ivosidenib in r/r AML Subjects With an IDH1 Mutation
NCT04421352Safety and Tolerability Evaluation of Low-dose Radiation in Combination With CS1001 in Relapsed SCLC Patients
NCT03505996A Study of CS1001 in Subjects With Relapsed or Refractory Classical Hodgkin Lymphoma
NCT05279300A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas
NCT05297890A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer
NCT03312842A Phase Ia/Ib Study of CS1001 in Subjects With Advanced Solid Tumors
NCT03809767A Study of CS1003 in Subjects With Advanced Solid Tumors or Lymphomas
NCT04200404A Study of CS1001 in Combination With Regorafenib in Patients With Advanced or Refractory Solid Tumors
NCT04233060A Study of CS3005 in Advanced Solid Tumors
NCT04187352A Study of CS1001 in Subjects With Esophageal Squamous Cell Carcinoma
NCT03475251A Study of CS1003 in Subjects With Advanced Solid Tumors
NCT03744403A Study of CS1001 in Subjects With Advanced Solid Tumors
NCT03595657A Study of CS1001 in Subjects With Relapsed or Refractory Extranodal Natural Killer/ T Cell Lymphoma(ENKTL)
NCT03728556A Study of CS1001 in Subjects With Stage III Non-Small Cell Lung Cancer
NCT04194775A Study of CS1003 in Subjects With Advanced Hepatocellular Carcinoma
NCT03789604A Study of CS1001 in Subjects With Stage IV Non-Small Cell Lung Cancer
NCT04162301A Study of CS3002 in Subjects With Advanced Solid Tumors
NCT04338724A Phase I Study of CS1002 in Subjects With Advanced Solid Tumors
NCT03736850Study of CS3006 in Subjects With Locally Advanced or Metastatic Solid Tumors
NCT03516123A Study of CS3006 in Subjects With Locally Advanced or Metastatic Solid Tumors
NCT04194801A Phase Ib/II Study of Fisogatinib(BLU-554) in Subjects With Hepatocellular Carcinoma
NCT04472858A Study of CS1001 in Combination With Donafenib in Subjects With Advanced Solid Tumors